EUVIMEDEUVIMED entdecken
Crossref

Targeting of VISTA with Cyclic Peptide-Based PET Tracers for Immune Checkpoint Imaging

Han Feng, Xiaoting Tian, Xiaofei Li, Lili Duan, Bo Li, Xinyu Wu, Yongju Gao, Xiaobo Wang iD

Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 3218-3227

DOI: 10.1021/acs.molpharmaceut.6c00318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 14.04.2026. Verfasst von Han Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou 450003, China. Hauptthemen laut MEDLINE: Peptides, Cyclic, Positron-Emission Tomography, Radiopharmaceuticals, B7 Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, National Natural Science Foundation of China, Henan Provincial Medical Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the distinct roles of VISTA in immune regulation, a better visualization of VISTA expression could clarify the tumor immune status and predict the responses to immunotherapy. However, only a few targeted probes are in development and insufficient to fulfill clinical demands. In this study, based on cyclic peptide antagonist AP1049, three novel radiotracers, [68Ga]Ga-AP1049, [68Ga]Ga-AHX-AP1049, and [68Ga]Ga-Pip-AP1049, were designed and developed for targeting and imaging VISTA in cancers. Molecular dynamics simulation revealed the better binding of NOTA-Pip-AP1049 for VISTA protein than that of NOTA-AP1049 and NOTA-AHX-AP1049. Protein binding assays demonstrated their high specificity and affinity with IC50 values of 58.10, 23.34, and 17.56 nM, respectively. The B16-F10 tumor uptake of three tracers was significant and decreased over time within 120 min, with tumor uptake values of 1.02 ± 0.21, 1.56 ± 0.21, and 1.89 ± 0.29 %ID/cc and tumor/muscle ratios of 2.36 ± 0.36, 3.10 ± 0.51, and 4.06 ± 0.71 at 30 min post-injection, respectively. Their in vivo specificity were verified by blocking studies. Furthermore, [68Ga]Ga-Pip-AP1049 PET could detect varying VISTA expression in B16-F10, 4T1, MC38, and CT26 xenograft models with tumor uptake values of 2.71 ± 0.43, 2.32 ± 0.44, 1.17 ± 0.30, and 0.85 ± 0.17 %ID/cc, which were in consistent with percentages of VISTA+ cells (r = 0.8712, P < 0.0001). Biodistribution data suggested their renal excretion and favorable pharmacokinetics. In conclusion, [68Ga]Ga-Pip-AP1049 is a promising tracer for PET imaging of VISTA expression in tumor microenvironment, indicating its potential as a companion diagnostic of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptides, CyclicPositron-Emission TomographyRadiopharmaceuticalsB7 AntigensAnimalsMiceHumansGallium RadioisotopesCell Line, TumorTissue DistributionFemaleMolecular Dynamics SimulationMice, Inbred C57BL

Stichwörter der Autor:innen

VISTA expressioncyclic peptideimmunotherapypositron emission tomographyradiotracers

Substanzen

Peptides, CyclicGallium RadioisotopesRadiopharmaceuticalsB7 Antigens

Autor:innen und Institutionen

  • Department of Pharmacy, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
  • Department of Nuclear Medicine, Henan Key Laboratory of Novel Molecular Probes and Clinical Translation in Nuclear Medicine, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou 45…

ORCID-Profile: Xiaobo Wang

Förderung

  • Natural Science Foundation of Henan Province
  • National Natural Science Foundation of China
  • Henan Provincial Medical Science and Technology Project

Zitieren

APA

Feng, H., Tian, X., Li, X., Duan, L., Li, B., Wu, X., Gao, Y., & Wang, X. (2026). Targeting of VISTA with Cyclic Peptide-Based PET Tracers for Immune Checkpoint Imaging. Molecular Pharmaceutics, 23(5), 3218-3227. https://doi.org/10.1021/acs.molpharmaceut.6c00318

Vancouver

Feng H, Tian X, Li X, Duan L, Li B, Wu X, et al. Targeting of VISTA with Cyclic Peptide-Based PET Tracers for Immune Checkpoint Imaging. Molecular Pharmaceutics. 2026;23(5):3218-3227. doi:10.1021/acs.molpharmaceut.6c00318

BibTeX
@article{Feng2026,
  author = {Feng, Han and Tian, Xiaoting and Li, Xiaofei and Duan, Lili and Li, Bo and Wu, Xinyu and Gao, Yongju and Wang, Xiaobo},
  title = {Targeting of VISTA with Cyclic Peptide-Based PET Tracers for Immune Checkpoint Imaging},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {3218--3227},
  doi = {10.1021/acs.molpharmaceut.6c00318}
}
Kostenlos starten →